Discover how Viking Therapeutics, Inc.'s VK2735 and VK2809 target obesity and NASH markets. Click for my updated look at VKTX ...

Mike Florio and Chris Simms spell out why the Vikings need to prioritize strengthening their secondary with the 2025 NFL Draft, given it has been a “chronic problem.” ...